Oncotarget is a peer-reviewed, open-access biomedical journal indexed in MEDLINE, PubMed, PMC, Scopus, and more.
Orchard Park, NY
Joined February 2016
- Tweets16.3K
- Following3.7K
- Followers3.4K
- Likes6.8K
Pinned Tweet
🔬 Scientific integrity is at the core of scholarly publishing.
A new editorial from Oncotarget highlights publishing industry trends, measurable journal comparisons, and future strategy.
🔗 doi.org/10.18632/oncotarget.…
#ScientificIntegrity #AcademicPublishing #OA #Research
ALT Figure 4: Post-tools era. Oncotarget versus Scientific Reports and PLOS One. The percentage of “High risk” articles identified by the tool “Argos” (as of 3/05/2026) in relation to the total number of articles published in a journal during a specific year in 2019–2025.
🎧 Listen to our #PressRelease on the #Editorial, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.”
soundcloud.com/oncotarget/tu…
#Cancer #Podcast #Audio #SoundCloud #PaperSpotlight #Lymphocytes #OA #Oncotarget
🎥 #OncotargetShort:
Intro #Video about the #Editorial "Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives." @mgumstjpr
🔗 bit.ly/4oG8f4n
#Cancer #PaperSpotlight #Lymphocytes #Immunotherapy #OA #Oncotarget
🔆 #PaperSpotlight:
The #Editorial, titled "Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives," was recently published in Volume 17.
#PressRelease ⬇️
bit.ly/3UwkntC
#Cancer #Lymphocytes #Immunotherapy #OA
🛡️ To maintain scientific integrity and reduce the risk of costly settlements related to image fraud, we recommend institutions subscribe to image forensics tools, establish dedicated image forensics teams, and encourage researchers to screen their manuscripts before publication.
ALT Oncotarget Scientific Integrity
Oncotarget retweeted
#PaperoftheDay: "p53 activation vs. stabilization: an acetylation tale from the C-terminal tail"
DOI ⬇️
doi.org/10.18632/oncoscience…
#Cancer #Oncology #Research #OpenAccess #Publishing #PeerReviewed #Journal
#PaperoftheDay: "Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer"
DOI ⬇️
doi.org/10.18632/oncotarget.…
#Cancer #Oncology #OpenAccess #Research #Publishing #PeerReviewed #Journal
✅ Read our #blog post about the precision #oncology paper, "Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment."
#Summary ⬇️
oncotarget.org/2025/09/24/pr…
#colorectalcancer #cancer
🔆 #PaperSpotlight:
A new #CaseReport was published on October 16, titled “WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer.” @BrownUniversity
🔗 bit.ly/4sJDAoV
#Cancer #Quote #ColonCancer #OA
🎧 Listen to our #PressRelease on the #CaseReport "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer."
soundcloud.com/oncotarget/in…
#Cancer #Podcast #Audio #SoundCloud #PaperSpotlight #ColonCancer #Press #OA
🎥 #OncotargetShort:
Abstract #Video about the #CaseReport "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer." @BrownUniversity
🔗 bit.ly/4sJDAoV
#Cancer #ColonCancer #ColorectalCancer #Oncotarget
🔆 #PaperSpotlight:
Case Report: "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer"
#PressRelease ⬇️
bit.ly/4dZGy2g
#Cancer #ColonCancer #Oncology #OA #PeerReviewed #Publishing #Oncotarget
Oncotarget retweeted
#PaperoftheDay: "A “two-hit” (chemo)therapy to improve checkpoint inhibition in cancer"
DOI ⬇️
doi.org/10.18632/oncoscience…
#Cancer #Oncology #Research #OpenAccess #Publishing #PeerReviewed #Journal
🎀 Oncotarget’s Special Collection on Breast Cancer:
oncotarget.com/collections/b…
#breastcancer #cancerresearch #openaccess #publishing
#PaperoftheDay: "Laryngeal leiomyosarcoma: A rare case report and literature review"
DOI ⬇️
doi.org/10.18632/oncotarget.…
#Cancer #Oncology #OpenAccess #Research #Publishing #PeerReviewed #Journal
✅ Read our #blog post about the #editorial perspective, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment."
#Summary ⬇️
oncotarget.org/2026/03/10/ca…
#cancer #TrendingWithImpact #Tcells #cancertherapy #perspective #openaccess #peerreview #journal #publishing #meded
🎥 Watch & subscribe to Oncotarget’s #YouTube channel for author #interviews and #video shorts!
Our Channel ⬇️
youtube.com/@OncotargetJourn…
🌐 Visit Oncotarget.net for insight from our distinguished #authors and for the latest #pressreleases by Oncotarget.
#openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA #press
✅ Read our #blog post about the #research paper, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells."
#Summary ⬇️
oncotarget.org/2025/04/22/ne…
#cancer #p53 #trendingwithimpact #openaccess #publishing
💬 How to contact #Oncotarget:
oncotarget.com/contact/
#OA #PeerReviewed #Journal #Research #Cancer #Oncology #MedEd #Publishing
🩺 Oncotarget’s Special Collection on Pancreatic Cancer:
oncotarget.com/collections/p…
#pancreaticcancer #cancerresearch #cancer #collections #openacess #publishing
